\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ n\\/a\ \(127\)\
\-\ large\\ soft\\ tissue\\ mass\\ in\\ right\\ lower\\ lobe\\ as\\ well\\ as\\ smaller\\ scattered\\ nodules\\.\ \(0\)\
\-\ myxofibrosarcoma\\ \\(metastatic\\)\ \(0\)\
\-\ metastatic\\ disease\\-\\ sarcoma\\,\\ prostate\\,\\ colon\\,\\ \\ \\ melanoma\\,\\ lymphoma\\,\\ testicular\\.\ \(0\)\
\-\ primary\\ lung\\ cancer\ \(1\)\
\-\ granulomatous\\ disease\\-\\ tb\\,\\ aspergillus\\,\\ histoplasma\\,\\ sarcoid\\.\ \(0\)\
\-\ 74\\ year\\ old\\ male\\ with\\ right\\ lower\\ lobe\\ mass\\ presents\\ for\\ biopsy\\.\ \(1\)\
\-\ the\\ patient\\ had\\ a\\ history\\ of\\ low\\ grade\\ myxofibrosarcoma\\ of\\ the\\ left\\ elbow\\ in\\ 1998\\.\\ \\ he\\ underwent\\ a\\ local\\ resection\\.\\ \\ the\\ tumor\\ recurred\\ and\\ he\\ underwent\\ an\\ above\\ the\\ elbow\\ amputation\\.\\ \\ he\\ was\\ disease\\ free\\ until\\ this\\ distant\\ metastatic\\ disease\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ myxofibrosarcoma\\:\\ 0\\.3971961025458439\ \(0\)\
\-\ elbow\\:\\ 0\\.25373673453635476\ \(0\)\
\-\ he\\:\\ 0\\.23875349228217063\ \(0\)\
\-\ disease\\:\\ 0\\.22565898474168616\ \(0\)\
\-\ metastatic\\:\\ 0\\.221128761792979\ \(0\)\
\-\ histoplasma\\:\\ 0\\.1890451953901136\ \(0\)\
\-\ underwent\\:\\ 0\\.18516289711764627\ \(0\)\
\-\ recurred\\:\\ 0\\.17271448039379955\ \(0\)\
\-\ aspergillus\\:\\ 0\\.1708286548675472\ \(0\)\
\-\ lobe\\:\\ 0\\.1553335930621086\ \(0\)\
\-\ amputation\\:\\ 0\\.15449793987123314\ \(0\)\
\-\ distant\\:\\ 0\\.14054907380709922\ \(0\)\
\-\ lower\\:\\ 0\\.1373532000452477\ \(0\)\
\-\ 74\\:\\ 0\\.13364622638168305\ \(0\)\
\-\ prostate\\:\\ 0\\.13017522051729516\ \(0\)\
\-\ testicular\\:\\ 0\\.12604160729748917\ \(0\)\
\-\ sarcoid\\:\\ 0\\.12604160729748917\ \(0\)\
\-\ melanoma\\:\\ 0\\.12550612421233487\ \(0\)\
\-\ smaller\\:\\ 0\\.12094733863555475\ \(0\)\
\-\ tb\\:\\ 0\\.1196735018430654\ \(0\)\
\-\ scattered\\:\\ 0\\.11694447629135173\ \(0\)\
\-\ local\\:\\ 0\\.1156900226686429\ \(0\)\
\-\ sarcoma\\:\\ 0\\.11274114878882188\ \(0\)\
\-\ until\\:\\ 0\\.11183487392139842\ \(0\)\
\-\ as\\:\\ 0\\.10798343875205373\ \(0\)\
\-\ the\\:\\ 0\\.10726763898744282\ \(0\)\
\-\ nodules\\:\\ 0\\.10678592531487104\ \(0\)\
\-\ free\\:\\ 0\\.1046166236392407\ \(0\)\
\-\ mass\\:\\ 0\\.10267151384079296\ \(0\)\
\-\ colon\\:\\ 0\\.10233146242513047\ \(0\)\
\-\ above\\:\\ 0\\.0969556537950112\ \(0\)\
\-\ grade\\:\\ 0\\.0966425562764225\ \(0\)\
\-\ biopsy\\:\\ 0\\.09420693727554927\ \(0\)\
\-\ cancer\\:\\ 0\\.0895173654443471\ \(0\)\
\-\ right\\:\\ 0\\.08911579561378156\ \(0\)\
\-\ resection\\:\\ 0\\.08614970624876302\ \(0\)\
\-\ lung\\:\\ 0\\.08175475588352542\ \(0\)\
\-\ lymphoma\\:\\ 0\\.08004125308717701\ \(0\)\
\-\ low\\:\\ 0\\.07711726161156338\ \(0\)\
\-\ soft\\:\\ 0\\.0715496717327669\ \(0\)\
\-\ tissue\\:\\ 0\\.07050121213073264\ \(0\)\
\-\ tumor\\:\\ 0\\.07029700507517246\ \(0\)\
\-\ large\\:\\ 0\\.06733916269827349\ \(0\)\
\-\ had\\:\\ 0\\.06696112334058436\ \(0\)\
\-\ in\\:\\ 0\\.06686682082593744\ \(0\)\
\-\ well\\:\\ 0\\.065075297814332\ \(0\)\
\-\ presents\\:\\ 0\\.0646515047414691\ \(0\)\
\-\ male\\:\\ 0\\.05983835386904338\ \(0\)\
\-\ of\\:\\ 0\\.052601479113473446\ \(0\)\
\-\ an\\:\\ 0\\.051392652001268024\ \(0\)\
\-\ history\\:\\ 0\\.05134712495031033\ \(0\)\
\-\ was\\:\\ 0\\.04683840287016319\ \(0\)\
\-\ this\\:\\ 0\\.04618095123067565\ \(0\)\
\-\ left\\:\\ 0\\.04584547165942533\ \(0\)\
\-\ patient\\:\\ 0\\.04371233383138188\ \(0\)\
\-\ year\\:\\ 0\\.04141825978544985\ \(0\)\
\-\ for\\:\\ 0\\.04073445380257319\ \(0\)\
\-\ old\\:\\ 0\\.03977586668045894\ \(0\)\
\-\ and\\:\\ 0\\.027771327298776433\ \(0\)\
\-\ with\\:\\ 0\\.026316454242354754\ \(0\)\
